Martha Quezado

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Disclosure: Nothing to disclose

Presentation(s):

• PATH-24 - CXCR4 is a Potential Therapeutic Target for Glioblastoma and Diffuse Intrinsic Pontine Gliomas

  Friday, November 22
  7:30 PM – 9:30 PM

• NIMG-32 - Challenges of imaging interpretation to predict Oligodendroglioma grade

  Friday, November 22
  7:30 PM – 9:30 PM

• PATH-20 - Investigation of clinically aggressive spinal cord ependymoma through methylation analysis

  Friday, November 22
  7:30 PM – 9:30 PM